Newsletter

Base Vodka

Total Labels 1
Approved 1
Expired 0

Shums, Karrikin Spirits Company LLC — Cincinnati, OH

Ohio

About Base Vodka

Base Vodka is a vodka brand originating from Ohio. According to TTB records, the spirit is classified as vodka with an alcohol content between 80 and 89 proof. The brand maintains one distinct product offering currently available through retail channels. The TTB label approval process for Base Vodka resulted in one approved label design on record. Recent approval activity indicates the brand received its label registration in 2024, reflecting current market presence. As an Ohio-based vodka producer, Base Vodka participates in the broader category of American-produced spirits. The brand's straightforward classification and single product line suggest a focused approach to vodka production and distribution. Base Vodka represents an entry in the vodka category, which remains one of the most widely consumed spirit types in the United States market. The specific proof range of 80 to 89 proof places the product within standard alcohol content parameters for vodka spirits. With TTB documentation establishing its regulatory compliance and market registration, Base Vodka maintains an official presence within documented spirit brands available to consumers seeking vodka options.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
Base Vodka

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2024-03-22 Shums, Karrikin Spirits Company LLC

Page 1 of 1

1

Base Vodka at a Glance

Base Vodka has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2024-03-22 and 2024-03-22. Produced in Ohio.

All information sourced from public TTB records.

Are you the owner or distributor of Base Vodka?

Claim this brand listing to update information or get featured. Contact [email protected].

Produced At

Shums, Karrikin Spirits Company LLC

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.